(Q40044147)

16 September 2017

title

Porous silicon surfaces: a candidate substrate for reverse protein arrays in cancer biomarker detection (English)

1 reference

16 September 2017

0 references

7

Thomas Laurell

1 reference

16 September 2017

6

György Marko-Varga

1 reference

16 September 2017

Anton Ressine

1

1 reference

16 September 2017

Irina Corin

2

1 reference

16 September 2017

Kerstin Järås

3

1 reference

16 September 2017

Ginevra Guanti

4

1 reference

16 September 2017

Cristiano Simone

5

1 reference

16 September 2017

publication date

1 December 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

28

1 reference

16 September 2017

issue

23

1 reference

16 September 2017

page(s)

4407-4415

1 reference

Development of functional protein microarrays for drug discovery: progress and challenges

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

Clinical proteomics: Applications for prostate cancer biomarker discovery and detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

Protein microarrays: Promising tools for proteomic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein chip technology

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarrays and proteomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Diagnostic and analytical applications of protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein arrays and microarrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Recent developments in protein microarray technology

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Global analysis of protein activities using proteome chips

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Developing a strategy for activity-based detection of enzymes in a protein microarray

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarrays: molecular profiling technologies for clinical specimens

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Use of high-throughput arrays for profiling differentially expressed proteins in normal and malignant tissues

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarrays as tools for functional proteomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarrays for antibody profiling: specificity and affinity determination on a chip

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarrays as a discovery tool for studying protein-protein interactions

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarrays: new tools for pharmaceutical development

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Protein microarray detection strategies: focus on direct detection technologies

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Proteomic approaches in cancer risk and response assessment

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Signal pathway profiling of prostate cancer using reverse phase protein arrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Cancer. Developing molecular biomarkers for cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Cyclin E and survival in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

The prognosis in spindle-cell sarcoma depends on the expression of cyclin-dependent kinase inhibitor p27(Kip1) and cyclin E

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

The use of molecular biology in diagnosis and prognosis of gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Overexpression of cyclin E and cyclin-dependent kinase 2 is correlated with development of hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Relationship between postoperative recurrence and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Integrated selective enrichment target--a microtechnology platform for matrix-assisted laser desorption/ionization-mass spectrometry applied on protein biomarkers in prostate diseases

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Integrated protein microchip assay with dual fluorescent- and MALDI read-out

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Macro-/nanoporous silicon as a support for high-performance protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Biocompatibility of surfaces for antibody microarrays: design of macroporous silicon substrates

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Porous silicon protein microarray technology and ultra-/superhydrophobic states for improved bioanalytical readout

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Solid supports for microarray immunoassays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Adsorption of IgG onto hydrophobic teflon. Differences between the F(ab) and F(c) domains

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Surface modification for direct immunoprobes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

A high-density poly(ethylene glycol) polymer brush for immobilization on glass-type surfaces

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Development of Multiplexed Protein Profiling and Detection Using Near Infrared Detection of Reverse-Phase Protein Microarrays

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Predicting the future of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Tumor-specific hyperactive low-molecular-weight cyclin E isoforms detection and characterization in non-metastatic colorectal tumors

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200700379

7 January 2021

Identifiers

DOI

10.1002/ELPS.200700379

1 reference

16 September 2017

1 reference